[Chronic myeloproliferative syndromes].
de Ozalla
C B
CB
Servicio de Hematología, Hospital Príncipe de Asturias, Universidad de Alcalá de Henares, Madrid.
García Suárez
J
J
D000328:Adult; D000367:Age Factors; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D002908:Chronic Disease; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000175:diagnosis / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009196:Myeloproliferative Disorders / Q000175:diagnosis / Q000628:therapy; D011087:Polycythemia Vera / Q000175:diagnosis / Q000628:therapy; D055728:Primary Myelofibrosis / Q000175:diagnosis / Q000628:therapy; D011379:Prognosis; D013577:Syndrome; D013922:Thrombocytosis / Q000175:diagnosis / Q000628:therapy
D000970:Antineoplastic Agents
Síndromes mieloproliferativos crónicos.